Literature DB >> 1813985

Time-dependent changes of markers associated with inflammation in the lungs of humans exposed to ambient levels of ozone.

H S Koren1, R B Devlin, S Becker, R Perez, W F McDonnell.   

Abstract

Acute exposure of humans to 0.4 ppm ozone results in reversible respiratory function decrements, and cellular and biochemical changes leading to the production of substances which can mediate inflammation and acute lung injury. While pulmonary function decrements occur almost immediately after ozone exposure, it is not known how quickly the cellular and biochemical changes indicative of inflammation occur in humans. Changes in neutrophils and PGE2 have been observed in humans as early as 3 hr (28) and as late as 18 hr post exposure (19). The purpose of this study was to determine whether inflammatory changes occur relatively rapidly (within 1 hr) following exposure to ozone, or if the cascade of events which are initiated by ozone and lead to inflammation, take some time to develop. We exposed 10 healthy volunteers twice: once to filtered air and once to 0.4 ppm ozone. Each exposure lasted for 2 hr at an exercise level of 60 L/min, and bronchoalveolar lavage was performed 1 hr following exposure. The data from this study were compared to those from a previous study in which 10 subjects were exposed to O3 under identical conditions except that bronchoalveolar lavage was performed 18 hr following exposure. The results of the present study demonstrate that O3 is capable of inducing rapid cellular and biochemical changes in the lung. These changes were detectable as early as 1 hr following a 2 hr exposure of humans to ozone. The profiles of these changes were different at 1 hr and 18 hr following ozone exposures.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1813985     DOI: 10.1177/0192623391019004-109

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  8 in total

1.  Ozone exposure effect on systemic prostaglandin F in rat plasma and urine may not reveal pulmonary damage through inflammation.

Authors:  Samar Basu; Maria B Kadiiska
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2017-09-12       Impact factor: 4.006

2.  Effects of cyclo-oxygenase inhibition on ozone-induced respiratory inflammation and lung function changes.

Authors:  M J Hazucha; M Madden; G Pape; S Becker; R Devlin; H S Koren; H Kehrl; P A Bromberg
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

3.  The Acute Effects of Exercising in Air Pollution: A Systematic Review of Randomized Controlled Trials.

Authors:  Andy Hung; Hannah Nelson; Michael S Koehle
Journal:  Sports Med       Date:  2021-09-09       Impact factor: 11.928

4.  Differential expression of pro-inflammatory and oxidative stress mediators induced by nitrogen dioxide and ozone in primary human bronchial epithelial cells.

Authors:  Jaime E Mirowsky; Lisa A Dailey; Robert B Devlin
Journal:  Inhal Toxicol       Date:  2016-07       Impact factor: 2.724

5.  Acute ozone-induced differential gene expression profiles in rat lung.

Authors:  Srikanth S Nadadur; Daniel L Costa; Ralph Slade; Robert Silbjoris; Gary E Hatch
Journal:  Environ Health Perspect       Date:  2005-12       Impact factor: 9.031

6.  Long-term concentrations of ambient air pollutants and incident lung cancer in California adults: results from the AHSMOG study.Adventist Health Study on Smog.

Authors:  W L Beeson; D E Abbey; S F Knutsen
Journal:  Environ Health Perspect       Date:  1998-12       Impact factor: 9.031

7.  Peripheral blood neutrophilia as a biomarker of ozone-induced pulmonary inflammation.

Authors:  Jenny A Bosson; Anders Blomberg; Nikolai Stenfors; Ragnberth Helleday; Frank J Kelly; Annelie F Behndig; Ian S Mudway
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

8.  Parameters of lung inflammation in asthmatic as compared to healthy children in a contaminated city.

Authors:  Benigno Linares Segovia; Gabriela Cortés Sandoval; Norma Amador Licona; Juan Manuel Guízar Mendoza; Estela Núñez Lemus; Diana Olivia Rocha Amador; Xóchitl Sofía Ramírez Gómez; Rebeca Monroy Torres
Journal:  BMC Pulm Med       Date:  2014-07-08       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.